BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.

Shahi, Mehdi Hayat; York, Daniel; Gandour-Edwards, Regina; Withers, Sita S; Holt, Roseline; Rebhun, Robert B

Shahi, Mehdi Hayat; York, Daniel; Gandour-Edwards, Regina; Withers, Sita S; Holt, Roseline; Rebhun, Robert B.

Afiliación

Shahi MH; The Comparative Oncology Laboratory and Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, United States of America.
York D; The Comparative Oncology Laboratory and Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Gandour-Edwards R; The Department of Pathology, Comprehensive Cancer Center, University of California Davis, Davis, California, United States of America.
Withers SS; The Comparative Oncology Laboratory and Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Holt R; The Comparative Oncology Laboratory and Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Rebhun RB; The Comparative Oncology Laboratory and Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, United States of America.

PLoS One ; 10(6): e0131006, 2015.

Article en En | MEDLINE | ID: mdl-26110620

Asunto(s)

Antineoplásicos/uso terapéutico; Neoplasias Óseas/metabolismo; Osteosarcoma/metabolismo; Complejo Represivo Polycomb 1/metabolismo; Adolescente; Animales; Neoplasias Óseas/tratamiento farmacológico; Neoplasias Óseas/patología; Carboplatino/farmacología; Carboplatino/uso terapéutico; Línea Celular Tumoral; Proliferación Celular/efectos de los fármacos; Modelos Animales de Enfermedad; Perros; Doxorrubicina/farmacología; Doxorrubicina/uso terapéutico; Resistencia a Antineoplásicos; Femenino; Regulación Neoplásica de la Expresión Génica; Compuestos Heterocíclicos con 2 Anillos/farmacología; Humanos; Masculino; Osteosarcoma/tratamiento farmacológico; Osteosarcoma/patología; Tiazoles/farmacología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / Complejo Represivo Polycomb 1 / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adolescent / Animals / Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google